
Ultra-low dose of cancer meds works, reduces costs by 90%, finds Tata study
Mumbai: Doctors in India are increasingly testing “dose optimisation” to make high-cost treatments affordable while cutting side-effects, and Tata Memorial Hospital’s latest findings underline how



